Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Heparin or M-EDTA in Preventing Catheter-Related Infections and Blockages in Patients at High Risk for a Catheter-Related Infection
This study has been completed.
Study NCT00378781 Information provided by National Cancer Institute (NCI)
First Received: September 19, 2006 Last Updated: November 16, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cancer
Additional conditions recognized in this trial
Communicable Diseases
Infection
Lymphoma, Large-Cell, Immunoblastic
Lymphoma, Non-Hodgkin
Neuroectodermal Tumors, Primitive, Peripheral
More general conditions related to this trial
Immune System Diseases
Immunoproliferative Disorders
Lymphatic Diseases
Lymphoma
Lymphoproliferative Disorders
Neoplasms
Neoplasms by Histologic Type
Neoplasms, Germ Cell and Embryonal
Neoplasms, Glandular and Epithelial
Neoplasms, Nerve Tissue
Neoplasms, Neuroepithelial
Neuroectodermal Tumors
Neuroectodermal Tumors, Primitive
Interventions listed in this trial
heparin
minocycline-EDTA
Additional drug interventions recognized in this trial
Calcium heparin
Edetic Acid
Minocycline
More general drug interventions related to this trial
Anti-Bacterial Agents
Anti-Infective Agents
Anticoagulants
Cardiovascular Agents
Chelating Agents
Fibrin Modulating Agents
Fibrinolytic Agents
Hematologic Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Back to top of Main Content
